351 results on '"Kishimoto M"'
Search Results
2. POS0036 BODY WEIGHT CHANGES AND TARGET SERUM URATE LEVEL: A LONGITUDINAL ANALYSES OF 63,493 PARTICIPANTS USING A LARGE ANNUAL MEDICAL EXAMINATION DATABASE IN JAPAN
3. POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY
4. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
5. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : étude randomisée de phase 3b
6. Forgotten treasures in the HST/FOC UV imaging polarimetric archives of active galactic nuclei
7. Li-like Aluminum Plasma Soft X-ray Laser by Means of Recombination Scheme
8. POS1541 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY
9. POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES
10. POS1119 ARE WE TREATING-TO-TARGET IN SPONDYLOARTHRITIS (SPA)? A ONE-YEAR ANALYSIS FROM THE ASIA PACIFIC LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY (APLAR) SPA REGISTRY
11. POS0029 WHOLE SPINE MRI IN AXIAL PSORIATIC ARTHRITIS
12. POS0027 INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
13. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
14. OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY
15. POS0302 TREAT-TO-TARGET IN SPONDYLOARTHRITIS (SPA): ARE THERE SEX-RELATED DIFFERENTIAL RESPONSES?
16. P308 A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: SOUL study
17. Dissecting the active galactic nucleus in Circinus – IV. MUSE-NFM observations unveil a tuning-fork ionized outflow morphology
18. Synthesis and Analyses of Acicular Spinel Iron Oxide Particles with Core-Shell Structure Containing Manganese Ferrite and Magnetite
19. PO.6.139 Effect and safety profile of belimumab and tacrolimus (B-T) combination therapy in 33 patients with systemic lupus erythematosus: a single-center retrospective analysis
20. PO.6.124 Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus
21. AB0761 Are we treating-to-target in spondyloarthritis (SpA)? A cross sectional analysis from the Asia Pacific League of Associations for Rheumatology (APLAR) SpA Registry
22. POS1025 COMPARISON OF COMPOSITE INDICES FOR DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: A POST-HOC ANALYSIS FROM SELECT-PsA 1
23. OP0016 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
24. POS0970 SAME OR DIFFERENT? ANALYSIS OF SIMILARITIES AND DIFFERENCES OF CROHN’S DISEASE AND ULCERATIVE COLITIS IN SPONDYLOARTHRITIS: AN ANCILLARY ANALYSIS FROM THE WORLDWIDE ASAS-perSpA STUDY.
25. AB0904 Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program
26. POS0081 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY
27. POS1031 EARLIER CLINICAL RESPONSE PREDICT LOW RATES OF RADIOGRAPHIC PROGRESSION IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT
28. Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique stratifiés selon la sévérité de l’atteinte cutanée à l’inclusion : analyse en sous-groupes de deux études de phase III
29. Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante active : résultats à 2 ans d’une étude randomisée, en double aveugle, contrôlée versus placebo avec extension en ouvert
30. Multiwavelength optical and NIR variability analysis of the Blazar PKS 0027-426
31. Pump-Probe Experiment for Temporal Profile Measurement of Plasma X-Ray Laser
32. Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study
33. P–019 Sperm parameter and ICSI / IVF outcomes after sperm selection using microfluidic sperm separator and density gradient centrifugation with swim-up in split semen sample
34. Spectropolarimetry of NGC 3783 and Mrk 509: Evidence for powerful nuclear winds in Seyfert 1 Galaxies
35. POS0969 UNVEILING AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS: AN ANCILLARY ANALYSIS OF THE ASAS-perSpA STUDY
36. AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY
37. OP0144 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
38. POS0975 CLINICAL CHARACTERISTICS OF NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN ASIAN COUNTRIES COMPARED TO OTHER REGIONS: RESULTS OF THE INTERNATIONAL CROSS-SECTIONAL ASAS-COMOSPA STUDY
39. OP0047 IDENTIFICATION OF CLINICAL PHENOTYPES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PERIPHERAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS ACCORDING TO PERIPHERAL MUSCULOSKELETAL MANIFESTATIONS: A CLUSTER ANALYSIS IN THE INTERNATIONAL ASAS-PERSPA STUDY
40. POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS
41. Prévalence et distribution des manifestations périphériques musculosquelettiques chez les patients atteints de spondyloarthrite (en incluant le rhumatisme psoriasique) : résultats de l’étude transversale internationale ASAS-PerSpA
42. Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante active : résultats à 1 an d’une étude randomisée, en double aveugle, contrôlée versus placebo, avec extension en ouvert
43. Identification des phénotypes cliniques selon les manifestations périphériques musculosquelettiques chez des patients atteints de spondyloarthrite (en incluant le rhumatisme psoriasique) : une analyse de clusters dans l’étude internationale ASAS-PerSpA
44. Development of the x-ray interferometer and the method of spatial and temporal synchronization of XRL and optical pulse
45. Source Development and Novel Applications of Laser-Driven Plasma X-ray Lasers in JAEA
46. Observation of Phase Transition Dynamics in BaTiO3 by X-ray Laser Speckle Technique
47. Energy Spectra of Photo- and Auger Electrons Generated by a Soft X-Ray Laser and Xe Cluster Interaction
48. Recent Progress in X-Ray Laser Research in JAEA
49. Time-of-Flight Measurements of Ion and Electron from Xenon Clusters Irradiated with a Soft X-Ray Laser Pulse
50. New Driver Laser System for Double Target X-Ray Lasers at JAEA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.